awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q50092012-2D21B813-87BC-4CF4-B3C8-66A4ACE4E6B9
Q50092012-2D21B813-87BC-4CF4-B3C8-66A4ACE4E6B9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q50092012-2D21B813-87BC-4CF4-B3C8-66A4ACE4E6B9
Ruxolitinib vs best available therapy for ET intolerant or resistant to hydroxycarbamide.
P2093
Q50092012-2D21B813-87BC-4CF4-B3C8-66A4ACE4E6B9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q50092012-2D21B813-87BC-4CF4-B3C8-66A4ACE4E6B9
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c7e189f6e5c953affcd546265b98c45eeed49715
P1545
14
http://www.w3.org/2001/XMLSchema#string
P2093
Steven Knapper
http://www.w3.org/2001/XMLSchema#string